ストックスクリーナーアプリを入手
0.3421
5.06%
-0.0198
前日終値:
$0.3619
開ける：
$0.35
24時間の取引高:
1.15M
Relative Volume:
0.08
時価総額：
$4.32M
収益：
$9.81M
当期純損益:
$-26.16M
株価収益率:
-0.00882
EPS:
-38.77
ネットキャッシュフロー:
$-17.45M
1週間 パフォーマンス:
-12.92%
1か月 パフォーマンス:
-11.19%
6か月 パフォーマンス:
-94.21%
1年 パフォーマンス:
-96.35%
1日の値動き範囲:
$0.3296
$0.3524
1週間の範囲:
$0.3296
$0.412
52週間の値動き範囲:
$0.30
$29.00
Reshape Lifesciences Inc Stock (RSLS) Company Profile
名前
Reshape Lifesciences Inc
セクター
電話
949-429-6680
住所
1001 CALLE AMANECER, SAN CLEMENTE
RSLS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
0.3421 | 4.32M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
131.18 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.05 | 138.41B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
370.94 | 129.62B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.88 | 104.91B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 40.53B | 5.54B | 4.18B | 259.90M | 7.00 |
Reshape Lifesciences Inc (RSLS) 最新ニュース
Market Resilience: ReShape Lifesciences Inc (RSLS) Finishes Weak at 0.36, Down -0.85 - DWinneX
Checking in on ReShape Lifesciences Inc (RSLS) after recent insiders movement - knoxdaily.com
ReShape Lifesciences secures patent for intragastric balloon By Investing.com - Investing.com Canada
ReShape Lifesciences amends asset purchase terms with Ninjour - Investing.com
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - GlobeNewswire
Revolutionary Weight Loss Tech: ReShape's New Patent Protects Self-Deflating Gastric Balloon Innovation - Stock Titan
ReShape Lifesciences Inc (RSLS)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - The Globe and Mail
Insider Sale Alert: ReShape Lifesciences Inc [RSLS] – Is it Time to sell? - knoxdaily.com
ReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation System - MSN
ReShape Shares Soar After USPTO's Notice of Allowance for Diabetes Neuromodulation Patent - marketscreener.com
ReShape Lifesciences secures patent for diabetes treatment By Investing.com - Investing.com South Africa
ReShape Lifesciences Gets USPTO's Notice of Allowance for Diabetes Neuromodulation Patent - marketscreener.com
ReShape Lifesciences (RSLS) Gains on Diabetes Neuromodulation Patent News - GuruFocus
ReShape Lifesciences secures patent for diabetes treatment - Investing.com
ReShape Lifesciences® Secures Patent for Innovative Vagal Neuromodulation Device to Treat Type 2 Diabetes with Enhanced Energy Efficiency - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for - GlobeNewswire
Revolutionary Diabetes Treatment Patent: ReShape's New Tech Uses 90% Less Energy Than Current Solutions - Stock Titan
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN
Why Did ReShape Lifesciences Plunge 11.04%? Earnings Miss, Bearish Sentiment - AInvest
Earnings call transcript: ReShape Lifesciences Q1 2024 sees cost cuts amid revenue drop - Investing.com UK
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
ReShape Lifesciences Reports 2024 Financial Results and Strategic Updates - TipRanks
Earnings call transcript: ReShape Lifesciences Q1 2024 sees cost cuts amid revenue drop By Investing.com - Investing.com South Africa
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - Benzinga
ReShape Lifesciences Shares Surge 82.2% After Partnership Announcement - AInvest
Dow Tumbles Over 800 Points; US Inflation Rate Falls In March - Benzinga
Penny Stock ReShape To Distribute FDA-Cleared Neuromuscular Device In US - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500 - Benzinga
Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket - Benzinga
ReShape secures exclusive deal for neuromuscular rehab tech By Investing.com - Investing.com South Africa
ReShape Lifesciences to Bring Motion Informatics' Neuromuscular Rehabilitation Devices to US - MarketScreener
ReShape secures exclusive deal for neuromuscular rehab tech - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market - The Manila Times
ReShape Lifesciences® Partners with Motion Informatics to - GlobeNewswire
AI Breakthrough: ReShape Brings Next-Gen Neuro Rehabilitation Platform to US Healthcare - Stock Titan
RSLS stock touches 52-week low at $0.34 amid market challenges - Investing.com India
ReShape Lifesciences Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - MarketScreener
ReShape Lifesciences Inc. SEC 10-K Report - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
ReShape Lifesciences shareholders approve key proposals By Investing.com - Investing.com Australia
Nasdaq Tumbles 100 Points; UniFirst Posts Upbeat Earnings - Benzinga
Pre-market Movers: IBG, JYD, SBFM, SPWH, RSLS… - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
ReShape Lifesciences shareholders approve key proposals - Investing.com
Why Sportsman's Warehouse Shares Are Trading Higher By Around 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Stock Market News For Apr 2, 2025 - Yahoo Finance
ReShape Lifesciences Delays Yearly Report Filing - TipRanks
Reshape Lifesciences Inc (RSLS) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.28%
大文字化:
|
ボリューム (24 時間):